# Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials

> **NCT00487513** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 40 (estimated)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **PROCEDURE:** Procurement of Follicular B Cell Lymphoma Cells

## Key facts

- **NCT ID:** NCT00487513
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487513, "Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00487513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*